Product References
Single-Cell RNA-Sequencing Reveals Lineage-Specific Regulatory Changes of Fibroblasts and Vascular Endothelial Cells in Keloids.
The Journal of investigative dermatology
Liu X,Chen W,Zeng Q,Ma B,Li Z,Meng T,Chen J,Yu N,Zhou Z,Long X
MA5-23759 was used in Immunohistochemistry-immunofluorescence to highlight the roles of transforming growth factor beta and Eph-ephrin signaling pathways in both the aberrant fibrogenesis and angiogenesis of keloids.
Sat Jan 01 00:00:00 EST 2022
CXCL12/CXCR4 axis supports mitochondrial trafficking in tumor myeloma microenvironment.
Oncogenesis
Giallongo C,Dulcamare I,Tibullo D,Del Fabro V,Vicario N,Parrinello N,Romano A,Scandura G,Lazzarino G,Conticello C,Li Volti G,Amorini AM,Musumeci G,Di Rosa M,Polito F,Oteri R,Aguennouz M,Parenti R,Di Raimondo F,Palumbo GA
MA5-23759 was used in Western Blot to demonstrate that myeloma mesenchymal stromal cells (MSCs) have decreased reliance on mitochondrial metabolism as compared to healthy MSCs and increased tendency to deliver mitochondria to multiple myeloma cells.
Fri Jan 21 00:00:00 EST 2022
CXCL12/CXCR4 axis supports mitochondrial trafficking in tumor myeloma microenvironment.
Oncogenesis
Giallongo C,Dulcamare I,Tibullo D,Del Fabro V,Vicario N,Parrinello N,Romano A,Scandura G,Lazzarino G,Conticello C,Li Volti G,Amorini AM,Musumeci G,Di Rosa M,Polito F,Oteri R,Aguennouz M,Parenti R,Di Raimondo F,Palumbo GA
MA5-23759 was used in Western Blot to demonstrate that myeloma mesenchymal stromal cells (MSCs) have decreased reliance on mitochondrial metabolism as compared to healthy MSCs and increased tendency to deliver mitochondria to multiple myeloma cells.
Fri Jan 21 00:00:00 EST 2022
Elevated CXCL12 in the plasma membrane of locally advanced rectal cancer after neoadjuvant chemoradiotherapy: a potential prognostic marker.
Journal of Cancer
Kim S,Yeo MK,Kim JS,Kim JY,Kim KH
MA5-23759 was used in Immunohistochemistry to suggest that CXCL12 expression in the plasma membrane of radioresistant LARC cells may be a predictive factor of recurrence and a viable therapeutic strategy to control radioresistant LARC recurrence.
Tue Jan 04 00:00:00 EST 2022
Elevated CXCL12 in the plasma membrane of locally advanced rectal cancer after neoadjuvant chemoradiotherapy: a potential prognostic marker.
Journal of Cancer
Kim S,Yeo MK,Kim JS,Kim JY,Kim KH
MA5-23759 was used in Immunohistochemistry to suggest that CXCL12 expression in the plasma membrane of radioresistant LARC cells may be a predictive factor of recurrence and a viable therapeutic strategy to control radioresistant LARC recurrence.
Tue Jan 04 00:00:00 EST 2022
S100A9-CXCL12 activation in BRCA1-mutant breast cancer promotes an immunosuppressive microenvironment associated with resistance to immunotherapy.
Nature communications
Li J,Shu X,Xu J,Su SM,Chan UI,Mo L,Liu J,Zhang X,Adhav R,Chen Q,Wang Y,An T,Zhang X,Lyu X,Li X,Lei JH,Miao K,Sun H,Xing F,Zhang A,Deng C,Xu X
MA5-23759 was used in Western Blot to provide a selective strategy for effective immunotherapy in patients with elevated S100A9 and/or CXCL12 protein levels.
Fri Mar 18 00:00:00 EDT 2022
S100A9-CXCL12 activation in BRCA1-mutant breast cancer promotes an immunosuppressive microenvironment associated with resistance to immunotherapy.
Nature communications
Li J,Shu X,Xu J,Su SM,Chan UI,Mo L,Liu J,Zhang X,Adhav R,Chen Q,Wang Y,An T,Zhang X,Lyu X,Li X,Lei JH,Miao K,Sun H,Xing F,Zhang A,Deng C,Xu X
MA5-23759 was used in Western Blot to provide a selective strategy for effective immunotherapy in patients with elevated S100A9 and/or CXCL12 protein levels.
Fri Mar 18 00:00:00 EDT 2022